… Our data suggests that the efficacy of inhaled beta 2 agonists administered using the spacer
device does not differ from that of the nebulizer. These findings are in agreement with those …

… (ICS), short-acting β 2 agonists (SABA), long-acting β 2 … In addition to improving drug delivery
to the airways, spacers … —jet nebulizers, ultrasonic nebulizers, mesh nebulizers, and smart …

… includes inhaled short-acting β2-agonists (SABA). The aim of … the device actuation and
inhalation due to lack of patient … the effectiveness of these two drug delivery systems in 100 …

… of children who use MDIs without devices, such as a spacers … some forgiveness in medication
delivery even when misused … The children were given either 4 ml of inhaled beta-2-agonist …

… of MDI with spacers versus nebulizers in drug delivery of … of salbutamol, a short-acting
beta-agonist (1). Recent randomized … nebulization and find the noise produced by the device as …

… (spacers) compared to nebulizers for the delivery of beta2-agonists for acute asthma 9 that
… costs of medications and delivery devices for each of the two modes of delivery of albuterol, …

… by nebulizer versus spacer device in children with acute asthma. J Pediatr. 1993;123:313-7. …
there are no differences in the administration of β-2 agonist via MDI-spacer or nebulizer. …

… device used, a maximum of 10% of the inhaled dose of a β 2 -… Metered Dose Inhaler (pMDI),
the amount of drug delivered to … to a spacer (pMDI-spacer) with that of a nebulizer to deliver …

… other drug delivery devices are not tolerated by the patient or are … saturation following nebulized
beta-2-agonists has also been … to a spacer may markedly affect drug delivery to children. …

… , a non-selective adrenergic agonist—to reduce … drug product (eg, nebulizers, spacers).
Clinicians have to keep in mind that device-only products are not required to conform with drug-…